Acadia Pharmaceuticals
ACAD
ACAD
255 hedge funds and large institutions have $2.38B invested in Acadia Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 90 increasing their positions, 80 reducing their positions, and 43 closing their positions.
Holders
255
Holders Change
-9
Holders Change %
-3.41%
% of All Funds
3.69%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
35
Increased
90
Reduced
80
Closed
43
Calls
$16M
Puts
$6.39M
Net Calls
+$9.63M
Net Calls Change
+$2.28M
Top Buyers
| 1 |
1
Man Group
London,
United Kingdom
|
$19.6M |
| 2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$21M |
| 3 |
O
3
OrbiMed
New York
|
$11.8M |
| 4 |
4
Two Sigma Investments
New York
|
$17.1M |
| 5 |
ITP
5
Iron Triangle Partners
Cos Cob,
Connecticut
|
$11.5M |
